openPR Logo
Press release

Vaginal Mesh Devices Facing New Scrutiny from FDA

01-09-2012 02:33 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen LLP reports that the U.S. Food and Drug Administration is ordering the makers of vaginal mesh implants to conduct additional research on the safety and efficacy of these devices.

Los Angeles, CA, January 6, 2012 – As the number of lawsuits filed in connection with defective vaginal mesh devices continues to escalate, the federal government is taking a closer look at the safety of the implants. The U.S. Food and Drug Administration recently ordered 33 mesh manufacturers to conduct additional safety testing on these devices to determine whether they should remain on the market.

Among the targets of the FDA’s scrutiny are the Johnson & Johnson Company and C. R. Bard. Johnson & Johnson is currently facing hundreds of lawsuits filed on behalf of women who say they suffered pain, bleeding, infection, swelling, blood vessel damage and other complications after receiving one of the company’s Ethicon Gynecare mesh implants. Bard is also facing numerous of claims involving its allegedly defective Avaulta mesh system.

The FDA has ordered the mesh manufacturers, which also include Boston Scientific Corp. and American Medical Systems, to provide as much as three years of research data on the devices. It’s believed that this information will be used to evaluate the benefits of mesh implants in comparison with the potential risks. FDA officials have not announced any plans to recall the implants at this time.

If you or a loved one experienced severe pain, swelling, infection, tissue damage or other complications after receiving a vaginal mesh implant, you may complete a MedWatch form by visiting www.fda.gov. It is also recommended that you contact an experienced vaginal mesh attorney to discuss your legal rights.

Nadrich & Cohen LLP offers confidential, no-cost consultations to women across the country that were harmed by a mesh device. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.vaginalmeshlegalclaims.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling vaginal mesh claims, Nadrich & Cohen LLP is also investigating cases involving Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, DePuy ASR Hip Recall, Zimmer Hip Recall, Wright Conserve Hips, Yaz, Yasmin, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan.

The time you have to file an injury claim is limited, so it’s important to act as quickly as possible to protect your rights. Call 1-800-722-0765 today to speak with a qualified personal injury expert or visit www.personalinjurylawcal.com.

###

Nadrich & Cohen LLP is a national law firm specializing in representing individuals who have been injured by defective medical devices, harmful prescription drugs, faulty products, car accidents, motorcycle accidents and dog bites. For more information, visit www.PersonalInjuryLawCal.com.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaginal Mesh Devices Facing New Scrutiny from FDA here

News-ID: 206375 • Views:

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for Johnson

Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the
Siltuximab Market Analysis By Top Keyplayers - Johnson & Johnson
The "Siltuximab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Siltuximab Market, 2024-2031 Verified Market Research's most recent report, "Siltuximab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future. Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and
Ebola Vaccine Market | CanSino Biologics Inc, Johnson & Johnson, Merck,
The global ebola vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ebola vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Medical Devices for Diagnostics in Vitro Market is Thriving Worldwide with Top K …
​Market Overview - According To A Recent Report Published By QYResearch, The Global Medical Devices for Diagnostics in Vitro Market Is Heading Towards The Inclined Path Of Growth With An Exceptional Growth Rate Over The Forecast Period Of 2023-2029. The Report Published Covers All The Aspects Of The Medical Devices for Diagnostics in Vitro Industry, Starting From The Industry Standard, Segments In Which The Industry Operates, Regional